Tesamorelin vs Sermorelin
Side-by-side comparison of Tesamorelin, Sermorelin — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Tesamorelin Tesamorelin (GHRH Analogue) Growth Hormone | Sermorelin Sermorelin Acetate (GHRH 1-29) Growth Hormone |
|---|---|---|
| Basics | ||
| Molecular type | GHRH Analogue | GHRH Analogue |
| Amino acids | 44 | 29 |
| Molecular weight | 5,135.8 Da | 3,357.9 Da |
| Half-life | ~30 min | ~10–20 min |
| Route(s) | Subcutaneous | Subcutaneous, IV (diagnostic only) |
| Mechanism & Research | ||
| Primary mechanism | Tesamorelin binds and activates pituitary GHRH receptors with the full-length 44-amino-acid native GHRH sequence, producing more complete pituitary signalling than the 29-amino-acid fragments (sermorelin, CJC-1295). Its … | Sermorelin binds GHRH receptors in the anterior pituitary with similar affinity to native GHRH and stimulates GH synthesis and secretion. Its mechanism is essentially identical to endogenous GHRH — it is distinguished pr… |
| Research status | FDA Approved | Research Compound |
| Evidence summary | Tesamorelin has the most extensive human clinical trial dataset of any GHRH analogue, accumulated during its FDA approval programme. Effects on visceral adiposity, metabolic parameters, and cognitive function have been s… | Sermorelin has more human clinical data than any other GHRH analogue due to its period of FDA approval. Adult studies have examined it for age-related GH decline, body composition, and sleep quality. |
| Protocol & Dosing | ||
| Typical dose | 2 mg/day | 200–500 mcg |
| Frequency | Once daily | Once daily at bedtime |
| Duration | 26–52 weeks (clinical) | 3–6 months |
| Timing | Before breakfast or bedtime | Bedtime (maximises nocturnal GH pulse) |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S2) | Prohibited (WADA S2) |
| Deeper reading | ||
| Related peptides | CJC-1295, Sermorelin, AOD-9604 | CJC-1295, Ipamorelin, Tesamorelin |
| Full profile | Read full Tesamorelin profile → | Read full Sermorelin profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.